Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

START and OneOncology are launching three new early-phase cancer trial sites in California, Texas, and New Jersey, expanding access in community settings where 70% of patients receive care.

Clinical trials are essential for advancing medical treatments, yet participation from Black communities remains low due to misinformation.

CeleCor Therapeutics has completed its multinational Phase 3 clinical trial of Disaggprotm (zalunfiban), an investigational heart-attack drug designed for rapid use at first point of medical contact ?